About SpeedBio India
SpeedBio India is a Healthcare company based in Delhi (India) founded in 2020 by Sanjiv Lakhanpal and Santosh Pandey. It manufactures IVD kits, provides contract manufacturing, lab consultancy, and marketing services. It operates on a B2B model. The company has 1 employees. Its Indian entity Speedbio India Private Limited reported revenue of ₹21.66 Cr. SpeedBio India offers products and services including RT-PCR COVID19 Kit, HLA Typing Service, IVD Solutions, and Contract Manufacturing. Its focus areas include Services Tech, Contract Manufacturing, Reagent Production and Diagnostics Tech.
Company details
SpeedBio is an IVD manufacturing company based in New Delhi, India, specializing in producing high-quality diagnostic kits and instruments using advanced technologies. They offer services like contract manufacturing of reagents, lab setup consultancy, and marketing strategies to support healthcare needs. Their products include RT-PCR based COVID-19 kits and HLA Typing via Next Generation Sequencing, aimed at delivering affordable diagnostics worldwide. They focus on preventive healthcare through genetic testing and population screening.
- Headquarters Delhi, India
- Employees 1
- Founders Sanjiv Lakhanpal, Santosh Pandey
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website speedbioindia.com
- Legal Name Speedbio India Private Limited
- Date of Incorporation 07 Oct, 2020
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹21.66 Cr
FY 2024 · +420% YoY
- Net Profit₹12.7 Lakh
FY 2024 · 1% margin
- EBITDA₹22.8 Lakh
FY 2024 · 1% margin
- Employee Count1
Associated legal entities of SpeedBio India
SpeedBio India operates through Speedbio India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Speedbio India Private Limited CIN U74999DL2020PTC371084 | Active | 07 Oct 2020 | New Delhi, Delhi | ₹21.7 Cr | 4 | View details |
Products & Services of SpeedBio India
SpeedBio India offers a comprehensive portfolio of products and services, including RT-PCR COVID19 Kit, HLA Typing Service, IVD Solutions, and Contract Manufacturing.
Kit for RT-PCR testing to detect COVID-19 infections
Next Generation Sequencing for HLA typing in diagnostics
Provides global IVD manufacturing facilities and equipment
Offers ready-to-use reagents and one-step PCR for fast results
Board of directors of Speedbio India Private Limited (SpeedBio India)
Speedbio India Private Limited is the primary company behind SpeedBio India. The board of Speedbio India Private Limited currently have 4 directors; the longest-serving is Reena, appointed in 2020. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Reena DIN 08908685 | Director | 07 Oct 2020 | 6 yrs 1 mo | Speedbio India Private Limited |
| Sanjiv Kumar Lakhan Pal DIN 09636882 | Director | 24 Aug 2024 | 2 yrs 2 mo | Speedbio India Private Limited |
| Santosh Kumar Pandey DIN 09636923 | Director | 24 Aug 2024 | 2 yrs 2 mo | Speedbio India Private Limited |
| Monu Rana DIN 11223454 | Additional Director | 14 Jan 2026 | 9 mo | Speedbio India Private Limited |
People of SpeedBio India
2 people are tracked at SpeedBio India (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Sanjiv Lakhanpal | Co-Founder, Managing Director | Leadership |
| Co-Founder, Managing Director | Leadership |
Complete people profiles for SpeedBio India
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SpeedBio India
Figures of Speedbio India Private Limited, the primary company behind SpeedBio India, for FY 2024. Revenue was ₹21.66 Cr (+420% year on year). Net profit was ₹12.7 Lakh (1% margin). EBITDA was ₹22.8 Lakh (1% margin). Revenue has grown at a compounded annual rate of +59% over three years.
- ₹21.66 CrRevenue · FY 2024 · +420% YoY
- ₹12.7 LakhNet profit · 1% margin
- ₹22.8 LakhEBITDA · 1% margin
- ₹1 LakhPaid-up capital
- +59%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Speedbio India Private Limited are on its company page.
Detailed financial statements for SpeedBio India
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SpeedBio India
SpeedBio India was founded in 2020.
SpeedBio India is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
SpeedBio India has 1 employees.
The primary company behind SpeedBio India, Speedbio India Private Limited, reported revenue of ₹21.66 Cr for FY 2024, up 420% year on year.
SpeedBio is an IVD manufacturing company based in New Delhi, India, specializing in producing high-quality diagnostic kits and instruments using advanced technologies. They offer services like contract manufacturing of reagents, lab setup consultancy, and marketing strategies to support healthcare needs. Their products include RT-PCR based COVID-19 kits and HLA Typing via Next Generation Sequencing, aimed at delivering affordable diagnostics worldwide. They focus on preventive healthcare through genetic testing and population screening.
SpeedBio India offers RT-PCR COVID19 Kit, HLA Typing Service, IVD Solutions, and Contract Manufacturing.
SpeedBio India operates through Speedbio India Private Limited.
The legal entities of SpeedBio India currently have 4 directors, including Reena, Sanjiv Kumar Lakhan Pal, Santosh Kumar Pandey and others.